NERON Inc.
PrivateLast Round
Seed
Mar 28, 2025
Total Funding Raised
$130,000
Company Overview
NERON Inc. is a biotechnology company that develops and sells gut microbiome-based products designed to improve mental well-being and address stress through the gut-brain axis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Mental Health, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NERON Inc. Comparables
Compare NERON Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Amare Global | 78% | |
| Bened Life | 78% | |
| Holobiome | 71% | |
NERON Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 28, 2025 | ||||
| Seed | Apr 19, 2024 |
NERON Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GLOCALINK Inc. | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 28, 2025
$130K round completed.
- Apr 19, 2024
Seed round raised with GLOCALINK Inc. as an investor.
NERON Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NERON Inc.'s valuation, stock price, and market status.